Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Effect of Intravenous Morphine vs Intravenous Ibuprofen and Acetaminophen vs Intravenous Ibuprofen

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosing a closed fracture of any of the bones of the body by an emergency medicine specialist~* Informed consent of the patient or his family to participate in the study~* Age 18 to 55 years~* Pain score of higher than or equal to 6 on the VAS scale~* Informed consent of the patient or family during the study~* No history of liver or kidney failure~* No history of gastrointestinal bleeding~* No history of heart failure~* No history of allergy to study drugs~* Absence of addiction (the patient is asked)~* Not decreased level of consciousness~* Lack of evidence of increased intra-cerebral pressure~* Not having an open fracture~* Absence of breathing disorders and respiratory problems~* No history of asthma~* Lack of history of frequent use of painkillers~* Not receiving any form of pain killer in the last few hours~Exclusion Criteria:~* Occurrence of any type of drug reaction or unusual complication during the study period~* Simultaneous Head trauma~* Simultaneous damage of nerves and blood vessels~* Multiple fractures~* Fracture other than limb~* Evidence of increased intra-cerebral pressure~* Decreased level of consciousness~* Breathing disorders and respiratory problems

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Ibuprofen (Type: ACTIVE_COMPARATOR): Ibuprofen 800 mg IV infusion over 20 min.
- Morphine (Type: ACTIVE_COMPARATOR): Morphine Sulfate 0.1 mg/kg IV
- Ibuprofen plus Acetaminophen (Type: ACTIVE_COMPARATOR): Ibuprofen 400 mg plus Acetaminophen 1000 mg IV infusion over 20 min.

Based on this trial design, predict the completion outcome and termination type (if applicable).